Viewing Study NCT01265433


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-08 @ 5:28 AM
Study NCT ID: NCT01265433
Status: COMPLETED
Last Update Posted: 2024-10-09
First Post: 2010-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Sponsor: Sellas Life Sciences Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Pleural Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GM-CSF View
None MONTANIDE ISA 51 View
None WT1 PEPTIDE SPECIFIC T CELLS View
None Vaccine View
None 10-134 View
None Galinpepimut-S View